Assertio Holdings, Inc. (ASRT)
23.46
+0.03
(+0.13%)
USD |
NASDAQ |
Jun 09, 16:00
23.46
0.00 (0.00%)
After-Hours: 20:00
Assertio Holdings SG&A Expense (Quarterly) : 11.14M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 145.36M |
| Merck & Co., Inc. | 2.70B |
| Theravance Biopharma, Inc. | 20.17M |
| Journey Medical Corp. | 10.11M |
| Tvardi Therapeutics, Inc. | 2.14M |